Browsing Tag
Alpha Wave Ventures
2 posts
Moonwalk Biosciences secures $70m Series B for adipose-targeted RNAi
Moonwalk Biosciences has secured $70 million to advance MW101 toward human testing, taking disclosed financing since launch to $127 million as the biotech pursues an adipose-targeted alternative to appetite-based obesity therapies.
September 13, 2026
HistoSonics secures $102m in blockbuster funding to transform liver cancer treatment forever
HistoSonics, a trailblazer in non-invasive histotripsy technology, has successfully concluded an oversubscribed $102 million Series D financing round.…
August 18, 2024